Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, today announced that the Company will host a conference call and live audio webcast on Thursday, November 5, 2020 at 5:00 p.m. ET to report its third quarter 2020 financial results and provide a corporate update.
In order to participate in the conference call, please dial (877) 303-6235 (domestic) or (631) 291-4837 (international) and refer to conference ID 1060606. To listen only, please dial (877) 638-9571 (domestic) or (760) 666-3586 (international) and refer to conference ID 1060606. The live webcast can be accessed under “Events & Presentations” in the Investors and Media section of the Company’s website at www.fatetherapeutics.com. The archived webcast will be available on the Company’s website beginning approximately two hours after the event.